Answers are grounded in this paper and cite their sources.
Demonstrates enhanced antitumor effects through a B7-H3-targeting antibody in cancer treatment, suggesting innovative therapies.
Together, our results suggest that the B7-H3-targeting VHH-Fc fusion protein 75-16-G1-2 is a potentially superior treatment for B7-H3-positive tumors by a mechanism of both VHH-induced activation of NK and T cells and Fc-mediated ADCC.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: